	ddMVAC versus gemcitabine-cisplatin as neoadjuvant treatment for muscle-invasive urothelial bladder cancer: a multicenter real-world study. Sci Rep Malik M, Sigorski D, Jacyk P, Ró, Chowaniec Z, Ge, Ornat J, Tupikowski K, Maciejczyk A, Radecka B, Lewandowski T, Czerko K, Bodnar L, Kopczy, Ramlau R, Iwanik B, Ko, Piszczek R, Jab, Cybulska-Stopa B. PMID: 42448827 [PubMed - as supplied by publisher]
	Re: De Luca et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2026;89:246-57. Eur Urol Messina E, Sciarra A, La Torre G, Panebianco V. PMID: 42448494 [PubMed - as supplied by publisher]
	Network meta-analysis of immune checkpoint inhibitors in BCG-naÃ¯ve, high-risk non-muscle-invasive bladder cancer. Urol Oncol McGrath J, Banerjee I, Ishiyama Y, Balaji KC. PMID: 42448544 [PubMed - as supplied by publisher]
	Cannabis use and testicular germ cell tumour subtypes in the french nationwide TESTIS case-control study. Eur J Cancer Coste A, Hosseini B, Praud D, Amadou A, Perrin J, Charbotel B, Schüz J, Fervers B, TESTIS study group. PMID: 42447513 [PubMed - as supplied by publisher]
	Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial. J Clin Oncol Srour SA, Chahoud J, Drakaki A, Curti BD, Gibney GT, Tang L, Jiang Y, Charmsaz S, Robbins PB, McLeroy J, Severyn CJ, Le Gall JB, Roberts ZJ, Tannir NM, Pal S, Kotecha RR. PMID: 42447427 [PubMed - as supplied by publisher]
	The Impact of Prostate Cancer Treatment on Work Participation: A Systematic Review. J Occup Rehabil Tomic D, Schellack SK, Abdel-Malek L, Jander C, Hettige ST, MacFarlane E, Millar J, Walker-Bone K. PMID: 42446789 [PubMed - as supplied by publisher]
	Comparative safety profiles of enzalutamide, olaparib, and lutetium Lu-177 vipivotide tetraxetan in patients with prostate cancer: a real-world disproportionality analysis of the FAERS database. World J Urol Li R, Li T, Yu J, Niu Y. PMID: 42446704 [PubMed - indexed for MEDLINE]
	[Stereotactic radiotherapy for primary renal cell carcinoma: new findings from the FASTRACK trials]. Strahlenther Onkol Trommer M, Dunst J. PMID: 42446589 [PubMed - as supplied by publisher]
	Testosterone Replacement Therapy in Men With Prostate Cancer on Active Surveillance: A Systematic Review of Oncological Safety. Andrology Aly M, Alshunaigat N, Habana Y, Elsayed Y, Jaafari FA, Chapman A, Bajis R, Bhatt J, Amer T. PMID: 42446168 [PubMed - as supplied by publisher]
	FocaSaBra: a prospective phase II study on focal salvage brachytherapy for prostate cancer recurrence after radiotherapy - trial design. Rep Pract Oncol Radiother Burchardt WM, Kluska A, Chiche, Zwierzchowski G, Burchardt E, Biel, Chyrek AJ. PMID: 42445704 [PubMed]
	Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis. BJUI Compass Westerberg M, Gedeborg R, Garmo H, Jäderling F, Stattin P, Robinson D. PMID: 42445323 [PubMed]
	Long-term Clinical Outcomes of Radiofrequency Ablation for Pathologically Diagnosed T1a Renal Cell Carcinoma: A 10-Year Single-center Experience. Interv Radiol (Higashimatsuyama) Fujimori M, Yamanaka T, Matsushita N, Kishi S, Nagata C, Kato H, Fukui H, Omori Y, Shima R, Nishikawa K, Kodama H, Takaki H, Yamakado K, Sakuma H. PMID: 42445307 [PubMed]
	Construction and validation of a machine learning-based prediction model for in-hospital acute kidney injury in patients with lung cancer complicated with sepsis: clinical and nursing applications. J Thorac Dis Zhang H, Zhang J. PMID: 42444975 [PubMed]
	Serum vitamin D levels and prostate cancer: an umbrella review and pooled analysis of observational meta-analyses. Front Oncol Wei L, Fan L, Wang H. PMID: 42444809 [PubMed]
	Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy Optimization. Int J Urol Matsuo T, Ozawa Y, Yorozu A, Hattori S, Kaneko Y, Nakamura K, Yagi Y, Nishiyama T, Saito S, Monma T. PMID: 42444597 [PubMed - indexed for MEDLINE]
	Demographic and histopathological features of patients with primary bladder cancer without recurrence in two-year follow-up. J Pak Med Assoc Uysal E, Yilmaz Y, Akin Y, Gorgel SN. PMID: 42444209 [PubMed - indexed for MEDLINE]
	Application of multi-sensory virtual reality in health education of prostate cancer: a randomized controlled trial. BMC Med Educ Fang H, Cheng S, Wong SY, Cheah KSL. PMID: 42443898 [PubMed - as supplied by publisher]
	Biochemical recurrence following definitive treatment of prostate cancer in Brazil: a retrospective cohort study. BMC Urol de Almeida Luz M, Pereira J, Kool R, Matheus WE, Soler R, Freire M, Bomfim G, Gonçalves SC. PMID: 42443889 [PubMed - as supplied by publisher]
	Latent profile analysis of health-related quality of life in patients with bladder cancer and abdominal wall stomas: a multicenter cross-sectional study. BMC Urol Ren J, Lu J, Xiong Z, Zhang Y, Hong H, Yang M. PMID: 42443879 [PubMed - as supplied by publisher]
	A Multimodal, Multitask Prediction Framework for Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma. J Imaging Inform Med Wang C, Jiang X, Wu C, Zhang L. PMID: 42443645 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180002

Page 1 of 9001



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy